Serine Protease Inhibitor A3K (Xiamen University)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSerine Protease Inhibitor A3K (Xiamen University)
Drug Alias NameSERPINA3KSA3K
ClassificationSmall molecules
Mechanisms of ActionWingless type MMTV integration site family protein inhibitorsAngiogenesis inhibitorsSerine protease inhibitors
TargetsSerine proteaseWingless type MMTV integration site family protein
Therapy Area/IndicationsCorneal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesXiamen University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXiamen University
Active IndicationsN/A
Inactive IndicationsCorneal Diseases

Other Information

ATC CodeN/A
Related LinksN/A